Jordan M Braciszewski, Abisola E Idu, Bobbi Jo H Yarborough, Scott P Stumbo, Jennifer F Bobb, Katharine A Bradley, Rebecca C Rossom, Mark T Murphy, Ingrid A Binswanger, Cynthia I Campbell, Joseph E Glass, Theresa E Matson, Gwen T Lapham, Amy M Loree, Celestina Barbosa-Leiker, Mary A Hatch, Judith I Tsui, Julia H Arnsten, Angela Stotts, Viviana Horigian, Rebecca Hutcheson, Gavin Bart, Andrew J Saxon, Manu Thakral, Deborah Ling Grant, Chaya Mangel Pflugeisen, Ingrid Usaga, Lawrence T Madziwa, Angela Silva, Denise M Boudreau
OBJECTIVE: The authors sought to characterize the 3-year prevalence of mental disorders and nonnicotine substance use disorders among male and female primary care patients with documented opioid use disorder across large U.S. health systems. METHODS: This retrospective study used 2014-2016 data from patients ages ≥16 years in six health systems. Diagnoses were obtained from electronic health records or claims data; opioid use disorder treatment with buprenorphine or injectable extended-release naltrexone was determined through prescription and procedure data...
June 16, 2022: Psychiatric Services: a Journal of the American Psychiatric Association